BPC-157 has been studied in structural, vascular, dermatological, and systemic models, with reports of activity in collagen regulation, extracellular matrix remodeling, angiogenesis, and wound closure
No Phase 1 human safety trial has been completed for either form
The semaglutide 5mg/mL dosage chart follows the same mathematical principles as the retatrutide charts above
Med Sci Monit 7:801819 Hancock JT, Neill SJ (2019) Nitric oxide: its generation and interactions with other reactive signaling compounds in plants
That said, there are plenty of people who have used this version with some positive effects
However, BPC-157 did not promote either NIH3T3 or HaCaT cell proliferation (data not shown)